Affiliation:
1. National University of Pharmacy, Kharkiv, Ukrainе
Abstract
Aim: Was a study of the role of neuroprotection therapy in rehabilitation possible neurological manifestations of post-COVID-19 syndrome and its effect on productivity in post-COVID-19 patients.
Materials and Methods: All patients underwent neuropsychological testing immediately after the COVID-19 treatment and after the administration of neuroprotection therapy.
Results: Аll patients voiced complaints typical of asthenic syndrome. Upon the neuroprotection, a verified (р<0,01) increase in well-being, activity and mood in both the Test groups was observed. Significantly, in the Test group 1 showed verified (р<0,01) increase in all indicators after the neuroprotection course, compared with the Test group 2 upon the implementation of a rehabilitation program only. Upon the neuroprotection and comprehensive rehabilitation program, both the test groups and the control group proved a decrease in the signs of asthenic syndrome, with Test groups 1 and 2 displayed verified effect (р<0,01). Both, upon neuroprotection and upon the four-week rehabilitation program, the following verified positive changes in the level of severity of asthenic syndrome were observed.
Conclusions: Early administration of neuroprotection able maliorating neurological manifestations of post-COVID-19 syndrome, reducing recovery time and enhansing productivity in post-COVID-19 patients.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献